@AMPath

We provide global expertise in molecular testing that drives patient care.

 Rockville, MD
amp.org
Joined September 2009
  • Tweets9.8K
  • Following3.5K
  • Followers9.4K
New AMP case report in CAP Today: "Comprehensive Molecular Characterization of an Aggressive Infant-Type Hemispheric Glioma with a Novel PRKAR2A::ALK Fusion" 👉 amp.org/AMP/assets/File/clin…
CAP TODAY (October 2026 issue) featuring a report on molecular characterization of aggressive infant-type hemispheric glioma with PRKAR2A::ALK fusion.

ALT CAP TODAY (October 2026 issue) featuring a report on molecular characterization of aggressive infant-type hemispheric glioma with PRKAR2A::ALK fusion.

3
1
125
🗓️ Today’s the last day to register for #AMP2026 at the standard registration rate. Register by 11:59 p.m. Eastern to save. Don’t wait until it’s too late! Register: ow.ly/WwAW50ZVvY3
AMP Annual Meeting & Expo 26 in Seattle, November 10-14, 2026, focusing on data transforming molecular medicine.

ALT AMP Annual Meeting & Expo 26 in Seattle, November 10-14, 2026, focusing on data transforming molecular medicine.

1
2
4
140
Today: Join us along with @ToniSepulvedaMD for a free webinar on alternative workflows for ordering biomarker and NGS tumor testing in colorectal and other gastrointestinal cancers covering multiple models and evaluate how these approaches affect outcomes. educate.amp.org/local/catalo…
Banner for AMP webinar on precision oncology testing protocols scheduled for Oct 20, 2026, featuring Dr. Antonia R. Sepulveda from George Washington University.

ALT Banner for AMP webinar on precision oncology testing protocols scheduled for Oct 20, 2026, featuring Dr. Antonia R. Sepulveda from George Washington University.

1
1
137
📅 Oct. 28 | 🕒 1 p.m. Eastern ➡️A practical path to NGS: Clonality and ultra-high sensitivity MRD assessment in lymphoid malignancies (hosted by Invivoscribe) Register for free: us06web.zoom.us/webinar/regi…
Free Invivoscribe webinar featuring Svea Stratmann on UHS-NGS for clonality assessment and Alice Scarpa on integrating IGH-based MRD testing with complementary methods in post-transplant B-ALL.

ALT Free Invivoscribe webinar featuring Svea Stratmann on UHS-NGS for clonality assessment and Alice Scarpa on integrating IGH-based MRD testing with complementary methods in post-transplant B-ALL.

2
5
366
🧛 Transform hematologic diagnostics with your molecular insights. @JMDiagn invites papers on NGS panels, fusion detection, MRD and molecular testing in leukemias, lymphomas and related disorders. Submit here: editorialmanager.com/jmdi/de…
Microscopic images of blood cells and tissues promoting JMD for advancements in hematopathology diagnostics.

ALT Microscopic images of blood cells and tissues promoting JMD for advancements in hematopathology diagnostics.

4
8
323
Advocacy update: In a letter, 19 members of Congress have urged CMS not to make unilateral changes to surgical pathology service valuations in the 2027 Medicare Physician Fee Schedule. Read the letter: amp.org/AMP/assets/File/advo…
2
1
3
361
➡️ Sunday: Last day to book your #AMP 2026 room with our discount. Hotel information: ow.ly/qBox50ZYeuY ➡️ Tuesday: Last day for regular registration. After that, the (higher) on-site rate applies. Register: ow.ly/Wk6h50ZYev0
Logo for AMP 2026 Annual Meeting & Expo in Seattle, Nov 10-14, 2026, promoting research in precision medicine and patient outcomes.

ALT Logo for AMP 2026 Annual Meeting & Expo in Seattle, Nov 10-14, 2026, promoting research in precision medicine and patient outcomes.

2
332
FREE webinar ➡️A practical path to NGS: Clonality and ultra-high sensitivity MRD assessment in lymphoid malignancies 📅 Oct. 28 | 🕒 1 p.m. Eastern us06web.zoom.us/webinar/regi…
Free Invivoscribe webinar featuring Svea Stratmann on UHS-NGS for clonality assessment and Alice Scarpa on integrating IGH-based MRD testing with complementary methods in post-transplant B-ALL.

ALT Free Invivoscribe webinar featuring Svea Stratmann on UHS-NGS for clonality assessment and Alice Scarpa on integrating IGH-based MRD testing with complementary methods in post-transplant B-ALL.

5
9
513
How can circulating tumor DNA (ctDNA) help detect minimal residual disease (MRD) in solid tumors? Join us Oct. 29 for a free webinar covering ctDNA-based MRD detection, emerging clinical applications and challenges in translating these tests into practice educate.amp.org/local/catalo…
Webinar on minimal residual disease in solid tumors focusing on circulating tumor DNA, featuring experts from Johns Hopkins and University of Minnesota.

ALT Webinar on minimal residual disease in solid tumors focusing on circulating tumor DNA, featuring experts from Johns Hopkins and University of Minnesota.

3
6
345
TODAY is the final broadcast in our Body of Knowledge series, based on the @JMDiagn papers. Join us at 1 p.m. ET to discuss: ✅Regulatory & standards organizations ✅U.S. lab regulations impacting clinical bioinformaticians ✅Data security best practices register.gotowebinar.com/reg…
Flyer for a clinical bioinformatics webinar on lab regulation and data security featuring speaker Ryan Schmidt and moderator Thomas Lee.

ALT Flyer for a clinical bioinformatics webinar on lab regulation and data security featuring speaker Ryan Schmidt and moderator Thomas Lee.

3
3
349
Load more